Jump to navigation
Merck and Bristol Myers-Squibb have developed a new diabetes drug, Pargluva. Last month, an FDA panel recommended approval. But it seems it can double the risk of heart attacks and strokes. Cheryl Glaser has more.
<iframe src="http://www.marketplace.org/node/14288/player/storyplayer" frameborder="0" scrolling="no" width="100%" height="240px"></iframe>